The COVID-19 pandemic
In December 2019, an outbreak of pneumonia of unknown origin was reported in Wuhan,
Hubei Province, China. Pneumonia cases were epidemiologically linked to the Huanan …
Hubei Province, China. Pneumonia cases were epidemiologically linked to the Huanan …
COVID-19: Discovery, diagnostics and drug development
Summary Coronavirus disease 2019 (COVID-19) started as an epidemic in Wuhan in 2019,
and has since become a pandemic. Groups from China identified and sequenced the virus …
and has since become a pandemic. Groups from China identified and sequenced the virus …
The epidemiology, diagnosis and treatment of COVID-19
P Zhai, Y Ding, X Wu, J Long, Y Zhong, Y Li - International journal of …, 2020 - Elsevier
In December 2019, the outbreak of the novel coronavirus disease (COVID-19) in China
spread worldwide, becoming an emergency of major international concern. SARS-CoV-2 …
spread worldwide, becoming an emergency of major international concern. SARS-CoV-2 …
[PDF][PDF] Chloroquine and hydroxychloroquine as available weapons to fight COVID-19
Repositioning of drugs to use as antiviral treatment is a critical need [1]. It is commonly very
26 badly perceived by virologists, as we experienced this in reporting the effectiveness of 27 …
26 badly perceived by virologists, as we experienced this in reporting the effectiveness of 27 …
Of chloroquine and COVID-19
F Touret, X de Lamballerie - Antiviral research, 2020 - Elsevier
Recent publications have brought attention to the possible benefit of chloroquine, a broadly
used antimalarial drug, in the treatment of patients infected by the novel emerged …
used antimalarial drug, in the treatment of patients infected by the novel emerged …
Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection
The recent emergence of the novel pathogenic SARS-coronavirus 2 (SARS-CoV-2) is
responsible for a worldwide pandemic. Given the global health emergency, drug …
responsible for a worldwide pandemic. Given the global health emergency, drug …
[HTML][HTML] Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and …
CC Lai, YH Liu, CY Wang, YH Wang, SC Hsueh… - Journal of Microbiology …, 2020 - Elsevier
Since the emergence of coronavirus disease 2019 (COVID-19)(formerly known as the 2019
novel coronavirus [2019-nCoV]) in Wuhan, China in December 2019, which is caused by …
novel coronavirus [2019-nCoV]) in Wuhan, China in December 2019, which is caused by …
A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19
Abstract Purpose COVID-19 (coronavirus disease 2019) is a public health emergency of
international concern. As of this time, there is no known effective pharmaceutical treatment …
international concern. As of this time, there is no known effective pharmaceutical treatment …
Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot …
P Gautret, JC Lagier, P Parola, L Meddeb… - Travel medicine and …, 2020 - Elsevier
Background We need an effective treatment to cure COVID-19 patients and to decrease
virus carriage duration. Methods We conducted an uncontrolled, non-comparative …
virus carriage duration. Methods We conducted an uncontrolled, non-comparative …
Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: A systematic search and a narrative review with a special reference to …
AK Singh, A Singh, A Shaikh, R Singh… - Diabetes & Metabolic …, 2020 - Elsevier
Background and aims No drugs are currently approved for Coronavirus Disease-2019
(COVID-19), although some have been tried. In view of recent studies and discussion on …
(COVID-19), although some have been tried. In view of recent studies and discussion on …